Stay informed Sign up for our newsletter and be the first to know.
Stay informed Sign up for our newsletter and be the first to know.
Brilliant Investment Thinking by Advisers for Advisers.
ASX
-0.70%
S&P
-2.64%
AUD
$0.71

China on a bull run, but can it last?

Markets have moved sharply to reprice Chinese assets upwards after the world’s second-largest economy signalled its reopening. However, some doubt the sustainability of the current bull market, saying key ingredients for a lasting recovery are missing.

Read More

ASX drops 0.6% as COVID, EOFY lead bourse lower

Markets continue to fall, travel stocks hit as Sydney faces lockdown, Costa enters trading halt The ASX 200 (ASX: XJO) finished 0.6% lower on Wednesday despite a strong overseas lead, with news of...
Read More

Banks help ASX eke out narrow gain

Bank rally not enough, Westpac hike dividend, job ads continue to surprise The ASX200 (ASX:XJO) rose just three points to begin the week, with a powerful day from the financials sector (+1.4%)...
Read More

ASX200 0.4% higher, quiet day of news

ASX200 0.4% higher, quiet day of news, Fortescue (ASX:FMG), Zip Co (ASX:Z1P) among the strongest The ASX200 (ASX:XJO) finished 0.4% higher on very light volume with most participants clearly opting for a...
Read More

ASX struggles under COVID-19 weight

ASX struggles under COVID-19 weight, banks fall, retail sales recover The ASX200 (ASX:XJO) struggled today, falling 1.1%, as concern around the NSW COVID-19 outbreak weighed on sentiment at the same time that volumes fall...
Read More

Is your portfolio ready for 2021?

This year's Sohn Hearts & Minds Conference, an annual one-day event that brings the finance and investment community together, saw a select group of fund managers share their best stock...
Read More

Pfizer’s Coronavirus vaccine – a closer look

A major milestone for Pfizer On 9 November 2020, Pfizer announced that its vaccine candidate, developed in collaboration with BioNTech, was more than 90 per cent effective in preventing COVID-19...
Read More

Vaccine ready – are we there yet?

This is an edited version of the full article, which is available here. The article pre-dated the US Election.   Executive summary Societies and governments around the world are looking...
Read More

Optimism abound, ASX up 4.4% for the week

Optimism abound, ASX up 4.4% for the week, Macquarie (ASX:MQG) profit falls 32% The week finished where it began, the ASX 200 (ASX:XJO) adding 0.8% taking the gain to 4.4% with every sector...
Read More

Thinking forward: Three ASX biotech stars

And still they keep coming - here's the fourth instalment of our series on the fascinating ASX cohort of medical device developers. As always, don't let the impressive sexiness of...
Read More

MDA market review: a watershed year

Managed Accounts, or Managed Discretionary Accounts (MDAs), are a relatively new investment solution available to consumers and financial advisers following recent advances in platform technology. MDAs have evolved to a...
Read More